Vista Pharmaceuticals Balance Sheet Annual

BSE: 524711 | NSE: - | ISIN: INE427C01021 | Sector: Biotechnology & Drugs

12.10 +0.04 (0.33%)Updated : 27 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.09	0.20	0.07	0.14
Cashand Short Term Investments	0.09	0.20	0.07	0.14
Accounts Receivable- Trade Net	14.28	11.25	10.46	2.17
Total Receivables Net	14.28	11.25	10.46	2.17
Total Inventory	6.79	7.68	9.33	9.68
Other Current Assets Total	2.23	4.62	3.70	3.25
Total Current Assets	23.40	23.75	23.56	15.24
Property/ Plant/ Equipment Total- Net	19.58	19.51	18.86	19.46
Intangibles Net	9.55	9.55	9.55	9.55
Long Term Investments	0.02	0.02	0.03	0.04
Note Receivable- Long Term	0.13	0.13	0.10	0.10
Other Long Term Assets Total	5.29	3.07	3.48	6.46
Total Assets	57.98	56.03	55.59	50.85
Accounts Payable	7.41	7.80	5.37	0.84
Notes Payable/ Short Term Debt	5.03	4.78	5.13	6.28
Other Currentliabilities Total	2.06	1.50	2.15	2.12
Total Current Liabilities	14.49	14.08	12.64	9.25
Long Term Debt	2.93	5.18	7.43	8.69
Total Long Term Debt	2.93	5.18	7.43	8.69
Total Debt	7.96	9.96	12.55	14.98
Other Liabilities Total	0.09	0.06	0.07	0.07
Total Liabilities	17.52	19.32	20.14	18.01
Common Stock Total	9.43	7.51	7.36	7.36
Retained Earnings( Accumulated Deficit)	31.03	29.20	28.09	25.49
Total Equity	40.46	36.71	35.45	32.85
Total Liabilities Shareholders' Equity	57.98	56.03	55.59	50.85
Total Common Shares Outstanding	4.69	3.76	3.68	3.68
Tangible Book Valueper Share Common Eq	6.59	7.23	7.04	6.33
Other Equity Total	-	0.00	-	-